薏苡附子散对支气管哮喘患者一秒率及生活质量的影响  被引量:4

Effect of Yiyi Fuzi powder on the FEV1/FVC% and the quality of life of patients with bronchial asthma

在线阅读下载全文

作  者:于宗学[1] 李强 孙桂琴[1] 胡东明[1] 

机构地区:[1]青岛市第三人民医院,山东青岛266308 [2]青岛市海慈医疗集团,山东青岛266033

出  处:《中医临床研究》2016年第30期13-15,共3页Clinical Journal Of Chinese Medicine

基  金:青岛市卫生局中医基金资助项目(编号:2008-zyy016)

摘  要:目的:探讨薏苡附子散对支气管哮喘急性发作期(寒哮证)患者肺功能及生活质量的影响。方法:120例患者按配对设计的方法分为两组,治疗组60例采用薏苡附子散治疗,对照组60例采用氨茶碱治疗,两组患者均同时吸入用布地奈德混悬液。治疗10 d后观察比较两组的临床疗效及FEV1/FVC%的变化,随访1年观察FEV1/FVC%及用哮喘控制测试(ACT)量表统计患者哮喘控制情况。结果:治疗组与对照组都能改善患者通气状况,但治疗组FEV1/FVC%较对照组明显改善(P<0.05),差异有显著性意义;随访1年显示哮喘患者缓解期FEV1/FVC%改善,用ACT量表显示治疗组哮喘控制情况较对照组明显改善,差异均有统计学意义。结论:薏苡附子散联合布地奈德治疗哮喘比氨茶碱联合布地奈德更能改善肺功能,延缓肺功能的减退,提高患者的生活质量。Objective :To observe the clinical efficacy of Yiyi Fuzi powder ton FEV1/FVC% and the quality of life in patients with bronchial asthma. Methods: 120 patients with asthma were divided into two groups in matched pair design. Sixty asthma patients of control group were treated with aminophylline. Treatment group were treated with Yiyi Fuzi powder. Both groups were treated with budesonide. After the treatment of ten days, the effect of two groups was compared, the changes of FEV1/FVC% of patients were assayed and the quality of life was measured with the score of asthma control test (ACT). Results: The improvement of FEV1/FVC% of the treatment group was significantly better than that of the control group (P〈0.05), the difference was of significance. After one year follow-up, the quality of life of patients in the treatment group was significantly better than that of the control group (P〈0.05). Conclusion: Yiyi Fuzi powder combined with budesonide were better than aminophylline and budesonide in the aspect of improving pulmonary function and the quality of life of patients with bronchial asthma.

关 键 词:薏苡附子散 支气管哮喘 肺功能 哮喘控制测试(ACT)量表 生活质量 

分 类 号:R256.12[医药卫生—中医内科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象